001     29672
005     20260201200959.0
022 _ _ |2 (DE-600)124034-1
|a 0026-895X
022 _ _ |a 0026-895X
|l 1521-0111
022 _ _ |a 1521-0111
024 7 _ |2 ZDBID
|a PERI:(DE-600)1475030-2
024 7 _ |2 ZDBPPN
|a ZDPPN:019680783
024 7 _ |2 EZBID
|a PERI:(DE-606)1938
024 7 _ |2 EZBID
|a PERI:(DE-606)1938
024 7 _ |2 OCLC
|a OCLC:643959273
024 7 _ |2 ISI
|a WOS:MOLECULAR PHARMACOLOGY
024 7 _ |2 SCOPUS
|a SCOPUS:19963
024 7 _ |2 Medline
|a medline:0035623
024 7 _ |2 JCR
|a JCR:MOL PHARMACOL
030 _ _ |2 DE-600
|a MOPMA
035 _ _ |a PERI:(DE-600)1475030-2
040 _ _ |a 9001
|b ger
|c DE-101
|d JOIN²
|e JOIN² journal identification
041 _ _ |a eng
044 _ _ |c XD-US
082 _ _ |2 22sdnb
|a 610
|q DE-600
082 7 4 |2 22sdnb
|a 610
|q DE-600
084 _ _ |2 fid
|a PHARM
|q DE-84
084 _ _ |2 ssgn
|a 15,3
084 _ _ |2 stub
|a MED 900z
210 0 _ |2 DE-600
|a Mol. Pharmacol.
210 0 _ |2 DE-600
|a Molec Pharm
210 0 _ |2 iso
|a Mol Pharmacol
210 0 _ |2 dnlm
|a Mol Pharmacol
210 0 _ |2 iso
|a Mol Pharmacol
242 2 0 |2 DE-600
|a Molecular pharmacology
|c American Society for Pharmacology and Experimental Therapeutics
|y en
242 2 0 |2 DE-600
|a Molecular pharmacology
|c American Society for Pharmacology and Experimental Therapeutics
245 _ _ |2 DE-600
|a Molecular pharmacology
|c American Society for Pharmacology and Experimental Therapeutics
|h online, print
246 3 _ |2 DE-600
|a Molecular pharmacology
246 3 _ |a Molecular pharmacology online
246 3 _ |a Molecular pharmacology
260 _ _ |a Bethesda, Md.
|b ASPET
|c 1965-
260 _ 1 |0 Host:(DE-Juel1)3067
|2 DE-Juel1
|a American Society for Pharmacology and Experimental Therapeutics (ASPET)
264 3 1 |a Bethesda, Md.
|b ASPET
|c 1965-
362 0 _ |2 DE-600
|a 1.1965 -
363 0 1 |2 DE-600
|8 1.1\x
|a 1
|i 1965
380 _ _ |2 marcgt
|a journal
500 _ _ |a Automatically generated record. (Updated: 2025-11-13)
540 _ _ |5 PubMed Central
|a Free access after 12 months. OpenAccess, coverage
|d 2025-11-13
650 _ 7 |0 4170397-2
|2 gnd
|9 rswk-swf
|a Molekularpharmakologie
650 _ 7 |0 4067488-5
|2 gnd
|9 rswk-swf
|a Zeitschrift
650 _ 7 |0 4511937-5
|2 gnd
|9 rswk-swf
|a Online-Ressource
650 _ 7 |0 ASJC:3004
|2 ASJC
|a Pharmacology
650 _ 7 |0 ASJC:1313
|2 ASJC
|a Molecular Medicine
653 1 0 |2 EZB-Subject
|a Medicine
653 1 0 |2 EZB-Subject
|a Chemistry and Pharmacology
653 1 0 |2 EZB-Keyword
|a Pharmazie
653 1 0 |2 EZB-Keyword
|a Pharmakologie
710 2 _ |0 (DE-101)000053147
|2 gnd
|4 isb
|a American Society for Pharmacology and Experimental Therapeutics
|e Herausgebendes Organ
776 0 8 |2 DE-600
|d Bethesda, Md. : American Society for Pharmacology and Experimental Therapeutics, 1965-2011
|i Erscheint auch als
|n Druck-Ausgabe
|t Molecular pharmacology
|w (DE-600)124034-1
|x 0026-895X
856 4 _ |d 0
|u https://ezb.ur.de/?1475030-2
|y EZB
856 4 _ |d 0
|u https://molpharm.aspetjournals.org
|y Verlag
856 4 _ |d 0
|u https://www.ncbi.nlm.nih.gov/pmc/?term="Mol Pharmacol"[journal]
|y PubMed Central
856 4 _ |d 0
|u https://www.sciencedirect.com/journal/molecular-pharmacology
|y Verlag
880 1 _ |2 DE-600
|a Molecular pharmacology
|c American Society for Pharmacology and Experimental Therapeutics
909 C O |o oai:juser.fz-juelich.de:63273
|p authority:PERI
|p authority
909 C O |o oai:juser.fz-juelich.de:63273
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b MOL PHARMACOL : 2022
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)0320
|2 StatID
|a DBCoverage
|b PubMed Central
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2025-11-13
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
|d 2025-11-13
936 _ _ |a Fast Forward (publish-ahead-of-print) articles are freely available upon publication. 2025 Verlagswechsel zu Elsevier.
980 _ _ |a PERI
980 _ _ |a AUTHORITY


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21